Prot# 07-AVR-123: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/10/08 → 4/10/11

Funding

  • Kendle International Inc. (07-AVR-123 // 07-AVR-123)
  • Avanir Pharmaceuticals (07-AVR-123 // 07-AVR-123)